EAN News

24. March 2020 Corona Virus Disease 2019 (COVID-19) is a new illness caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which typically causes fever, cough, respiratory symptoms, diarrhea, reduction of smell and taste sensation and may… Continue Reading

No change to the conditions of use of the direct oral anticoagulants Eliquis (apixaban), Pradaxa (dabigatran etexilate) and Xarelto (rivaroxaban) is needed following a review of the results of a European study of real-world data for these medicines. The study,… Continue Reading

As part of the EU’s Civil Protection Mechanism, on 19 March, the European Commission decided to create a Strategic RescEU Stockpile of medical equipment such as ventilators and protective masks to help EU countries in the context of the COVID-19… Continue Reading

Rare Disease Day was launched in 2008 by EURORDIS, an alliance of patient organisations, and its Council of National Alliances, starting as a European event. It is now a major international event celebrated by rare disease organizations across the globe with… Continue Reading

Neurologists working at the Reggio Emilio Hospital in Italy have provided a presentation on the impact the COVID-19 pandemic has had on their Neurology Unit and their experience treating COVId-19 patients with neurological conditions.

This article addresses the difficult issue of how to allocate overstretched resources during a pandemic and proposes six recommendations based on principles of equality and maximising benefits.

Find out which sessions not to miss at EAN 2020 in Paris

EAN signed a Memorandum of Understanding withISNA – International Society for Neuro-Immunology joining forces to promote optimal cooperation in Europe between both societies.

EAN signed a Memorandum of Understanding with EPA – European Psychiatric Association joining forces to promote optimal cooperation in Europe between both societies.

Dr. Tom Jenkins, Chair of the EAN e-Communication Committee interviews Prof. Didier Leys, Editor in Chief of the European Journal of Neurology

As a society aiming to promote excellence in neurology across Europe, one of the European Academy of Neurology’s greatest assets is undoubtedly the strong support from its National Neurological Society Members. As a region with a wide variety of languages, cultures, jurisdictions and needs, Europe certainly presents some challenges when it comes to coordinated action, but what we all have in common as neurologists is a strong desire to reach for excellence, ensure the best possible patient care and to work together to achieve it.

For March 2020, we have selected: Olanow et al, Apomorphine sublingual film for off episodes in Parkinson’s disease: a randomised, double-blind, placebo-controlled phase 3 study. Lancet Neurology; 19: 135-44.

Ireland – Hibernia (“land of winter” according to the Romans) – sits as the last outpost of North-Western Europe before the vast Atlantic Ocean that separates us from North America. Anyone who has visited the Cliffs of Moher (Figure) on the West Coast of Ireland will appreciate the precipitous point at which Europe ends.